BlackRock Health Sciences Term Trust Files Proxy Statement

TL;DR

BlackRock Health Sciences Term Trust filed its proxy statement on 6/12/24. Shareholders need to pay attention to upcoming votes.

AI Summary

BlackRock Health Sciences Term Trust (the "Trust") is filing a Definitive Proxy Statement (DEFA14A) on June 12, 2024. This filing concerns the Trust's proxy materials, indicating it is seeking shareholder approval or providing important information for an upcoming meeting. The filing does not contain specific financial figures or proposals but serves as official communication to shareholders.

Why It Matters

This filing is important for shareholders of the BlackRock Health Sciences Term Trust as it contains official information and proposals that may require their vote or attention regarding the Trust's operations and governance.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement and does not inherently present new financial risks to investors.

Key Players & Entities

• BlackRock Health Sciences Term Trust (company) — Registrant
• 20240612 (date) — Filing Date
• DEFA14A (document) — Filing Type

FAQ

Key Financial Figures

• $2.4 — Year* in 2023. Responsible for roughly $2.4 trillion in assets, Rick Rieder is a me

Filing Documents

• d849947ddefa14a.htm (DEFA14A) — 15KB
• g846661g03k03.jpg (GRAPHIC) — 274KB
• g846661g06p06.jpg (GRAPHIC) — 259KB
• g846661g08b01.jpg (GRAPHIC) — 231KB
• g846661g08b02.jpg (GRAPHIC) — 217KB
• g846661g08b03.jpg (GRAPHIC) — 214KB
• 0001193125-24-159658.txt ( ) — 1661KB

From the Filing

HEALTH SCIENCES TERM TRUST BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Definitive Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 BLACKROCK HEALTH SCIENCES TERM TRUST (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Defend Your Fund Defend Your Fund (by BlackRock)1 follower Promoted Only a few days remain for investors of BlackRocks contested closed-end funds (CEFs) to vote FOR BlackRocks decades of CEF experience and qualified board nominees, and AGAINST Sabas proposals and nominees using ONLY the WHITE card. #DefendYourFund BlackRock BlackRock Closed-End Fund Investors: only a few days remain. Vote for BlackRocks nominees. > Vote FOR BlackRock board nominees today BlackRock CEF Shareholders: Vote Today | BlackRock (Learn more blackrock.com Defend Your Fund Defend Your Fund (by BlackRock)... 1 follower Promoted Only a few days remain for all shareholders at BlackRocks contested closed-end funds (CEFs) to make their voices heard on the future of their investments. Vote FOR BlackRocks board nominees and AGAINST Sabas proposals and nominees using ONLY the WHITE card. #DefendYourFund BlackRock BlackRock Closed-End Fund Investors: Make your voice heard. Vote today. > Vote FOR BlackRock board nominees today CEF Shareholders: Vote for the Future of Your Investment | BlackRock Learn more blackrock.com BlackRock Proposals BlackRock Nominees BlackRock Portfolio Managers BlackRock Funds Truth About Saba BLACKROCK CLOSED-END FUNDS The future of your long-term investment depends on you Closed-end funds (CEFs) have been at the heart of BlackRock since our founding in 1988. At this years Annual Meetings in June, activist hedge fund, Saba Capital Management L.P. (Saba), is attempting to install its own hand-picked nominees with little to no experience, and, in some instances, fire BlackRock as investment manager of one or more CEFs in which you are invested. We are asking all shareholders to make their voices heard. If Saba prevails, your investments may be at risk. > Cast your vote Whats at stake How to vote Board nominees Portfolio Managers > This proxy season counts. Vote the WHITE proxy card now! X ISS backs most BlackRock nominees, rejects Sabas CEF proposals Independent proxy advisor Institutional Shareholder Services (ISS) rejected Saba s proposals and several of its board nominees for certain BlackRock contested closed-end funds. > View press release OUR PERFORMANCE See how we have improved discounts and delivered strong performance Saba has indicated that BlackRock CEFs are not performing as they were intended. This is factually inaccurate. See how we have improved discounts and outperformed benchmarks in recent years. > View performance Were setting the record straight Boaz Weinstein, Founder and CIO of Saba, has made several unfounded claims about BlackRock, your Funds and their Boards. We want our shareholders to hear the truth from us. > The truth about SABA The stakes could not be higher This proxy season, Saba has launched proxy campaigns targeting BlackRock CEFs, claiming to act in the best interests of shareholders but in reality seeking to benefit itself by making a quick profit at your expense. Here are the two types of proposals Saba is submitting for the shareholder meetings: 01. Director nominations Saba is seeking to install its own hand-picked nominees, including, in some instances, a majority of the Board. 02. Terminate investment management agreement If approved, BlackRock would no longer manage the following Funds - BCAT, BFZ, BIGZ, BMEZ, BSTZ, ECAT. Learn more > Board nominees up for election Your qualified Board is under attack by a self-serving activist hedge fund. View some of the BlackRock Board nominees that are up for election. Click below to view the full list. Robert Fairbairn Cynthia L. Egan J. Phillip Holloman Vice Chairman and member of the Global Executive Committee at BlackRock Former President of Retirement Plan Services at T. Rowe Price Group. Board Chair for The Hanover Insurance Group and Lead Independent Director for Huntsman Corporation Former President and Chief Operating Officer of Cintas Corporation and director of PulteGroup, Inc. and Rockwell Automation Inc. View all nominees > Lead Portfolio Managers BlackRocks CEFs are managed by some of the industrys most influential t

View Full Filing

View this DEFA14A filing on SEC EDGAR